PL312718A1 - Competitors and opponents of human interleukine-10 - Google Patents
Competitors and opponents of human interleukine-10Info
- Publication number
- PL312718A1 PL312718A1 PL94312718A PL31271894A PL312718A1 PL 312718 A1 PL312718 A1 PL 312718A1 PL 94312718 A PL94312718 A PL 94312718A PL 31271894 A PL31271894 A PL 31271894A PL 312718 A1 PL312718 A1 PL 312718A1
- Authority
- PL
- Poland
- Prior art keywords
- opponents
- competitors
- human interleukine
- interleukine
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9894393A | 1993-07-26 | 1993-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL312718A1 true PL312718A1 (en) | 1996-05-13 |
Family
ID=22271670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL94312718A PL312718A1 (en) | 1993-07-26 | 1994-07-22 | Competitors and opponents of human interleukine-10 |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0711346A1 (en) |
| JP (1) | JPH08507930A (en) |
| KR (1) | KR960704041A (en) |
| CN (1) | CN1127529A (en) |
| AU (1) | AU681178B2 (en) |
| CA (1) | CA2168110A1 (en) |
| CZ (1) | CZ23396A3 (en) |
| FI (1) | FI960353A0 (en) |
| HU (1) | HUT73463A (en) |
| IL (1) | IL110413A0 (en) |
| NO (1) | NO960309L (en) |
| NZ (1) | NZ269663A (en) |
| PL (1) | PL312718A1 (en) |
| SG (1) | SG43798A1 (en) |
| SK (2) | SK150596A3 (en) |
| WO (1) | WO1995003411A1 (en) |
| ZA (1) | ZA945434B (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996001318A1 (en) * | 1994-07-05 | 1996-01-18 | Steeno Research Group A/S | Immunomodulators |
| GB2304047A (en) | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
| AUPN481295A0 (en) * | 1995-08-16 | 1995-09-07 | Medvet Science Pty. Ltd. | Agonists of haemopoietic growth factors |
| AU4385696A (en) | 1996-01-18 | 1997-08-11 | Christian Gronhoj Larsen | Synthetic il-10 analogues |
| DE19851675A1 (en) * | 1998-11-10 | 2000-05-11 | Bayer Ag | Human interleukin-10 mutant proteins |
| JP2004500412A (en) | 2000-03-31 | 2004-01-08 | アイデック ファーマスーティカルズ コーポレイション | Combination of anti-cytokine antibody or antagonist and anti-CD20 for treatment of B-cell lymphoma |
| ATE516820T1 (en) | 2000-09-29 | 2011-08-15 | Schering Corp | PEGYLATED INTERLEUKIN 10 |
| US7261882B2 (en) | 2003-06-23 | 2007-08-28 | Reagents Of The University Of Colorado | Methods for treating neuropathic pain by administering IL-10 polypeptides |
| EP1712241A1 (en) | 2005-04-15 | 2006-10-18 | Centre National De La Recherche Scientifique (Cnrs) | Composition for treating cancer adapted for intra-tumoral administration and uses thereof |
| US8524678B2 (en) | 2005-05-31 | 2013-09-03 | The Regents Of The University Of Colorado, A Body Corporate | Method for delivering genes |
| ES2606034T3 (en) | 2006-09-28 | 2017-03-17 | Merck Sharp & Dohme Corp. | Pegylated IL-10 for use in the treatment of lymphoma |
| JP5840494B2 (en) * | 2008-10-02 | 2016-01-06 | エマージェント プロダクト デベロップメント シアトル， エルエルシー | Multi-target binding protein of CD86 antagonist |
| PL2379115T3 (en) | 2008-12-17 | 2018-03-30 | Merck Sharp & Dohme Corp. | Mono- and di-peg il-10 production; and uses |
| WO2013070076A1 (en) | 2011-11-08 | 2013-05-16 | Umc Utrecht Holding B.V. | Fusion protein comprising an interleukin 4 and interleukin |
| CN106913865A (en) | 2013-04-18 | 2017-07-04 | 阿尔莫生物科技股份有限公司 | The method that disease and illness are treated using interleukin 10 |
| AU2014257123A1 (en) * | 2013-04-24 | 2015-10-15 | Armo Biosciences, Inc. | Interleukin-10 compositions and uses thereof |
| CA2914837A1 (en) | 2013-06-17 | 2014-12-24 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
| WO2015031316A1 (en) | 2013-08-30 | 2015-03-05 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| JP6660297B2 (en) | 2013-11-11 | 2020-03-11 | アルモ・バイオサイエンシーズ・インコーポレイテッド | Methods of using interleukin-10 to treat diseases and disorders |
| US10293043B2 (en) | 2014-06-02 | 2019-05-21 | Armo Biosciences, Inc. | Methods of lowering serum cholesterol |
| EP3206713A4 (en) | 2014-10-14 | 2018-06-27 | Armo Biosciences, Inc. | Interleukin-15 compositions and uses thereof |
| ES2941234T3 (en) | 2014-10-22 | 2023-05-19 | Armo Biosciences Inc | Methods of using interleukin-10 for the treatment of diseases and disorders |
| WO2016126615A1 (en) | 2015-02-03 | 2016-08-11 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| JP7121496B2 (en) | 2015-05-28 | 2022-08-18 | アルモ・バイオサイエンシーズ・インコーポレイテッド | Pegylated interleukin-10 for use in cancer therapy |
| AU2016312510A1 (en) | 2015-08-25 | 2018-03-08 | Armo Biosciences, Inc. | Methods of using Interleukin-10 for treating diseases and disorders |
| GB2620875A (en) | 2019-04-19 | 2024-01-24 | Synerkine Pharma B V | A fusion protein comprising IL13 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01113229A (en) * | 1987-10-27 | 1989-05-01 | Inahata Kenkyusho:Kk | Porous material of honeycomb structure |
| IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
| WO1993002693A2 (en) * | 1991-08-06 | 1993-02-18 | Schering Corporation | Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
-
1994
- 1994-07-22 CA CA002168110A patent/CA2168110A1/en not_active Abandoned
- 1994-07-22 JP JP7505238A patent/JPH08507930A/en active Pending
- 1994-07-22 CN CN94192880A patent/CN1127529A/en active Pending
- 1994-07-22 HU HU9503983A patent/HUT73463A/en unknown
- 1994-07-22 WO PCT/US1994/008052 patent/WO1995003411A1/en not_active Application Discontinuation
- 1994-07-22 CZ CZ96233A patent/CZ23396A3/en unknown
- 1994-07-22 IL IL11041394A patent/IL110413A0/en unknown
- 1994-07-22 SK SK1505-96A patent/SK150596A3/en unknown
- 1994-07-22 PL PL94312718A patent/PL312718A1/en unknown
- 1994-07-22 KR KR1019960700358A patent/KR960704041A/en not_active Application Discontinuation
- 1994-07-22 NZ NZ269663A patent/NZ269663A/en unknown
- 1994-07-22 AU AU73996/94A patent/AU681178B2/en not_active Ceased
- 1994-07-22 SG SG1996000969A patent/SG43798A1/en unknown
- 1994-07-22 SK SK83-96A patent/SK8396A3/en unknown
- 1994-07-22 EP EP94923956A patent/EP0711346A1/en not_active Withdrawn
- 1994-07-22 ZA ZA945434A patent/ZA945434B/en unknown
-
1996
- 1996-01-25 NO NO960309A patent/NO960309L/en unknown
- 1996-01-26 FI FI960353A patent/FI960353A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995003411A1 (en) | 1995-02-02 |
| SK8396A3 (en) | 1997-03-05 |
| EP0711346A1 (en) | 1996-05-15 |
| SK150596A3 (en) | 1997-04-09 |
| CZ23396A3 (en) | 1996-05-15 |
| HU9503983D0 (en) | 1996-03-28 |
| CA2168110A1 (en) | 1995-02-02 |
| AU681178B2 (en) | 1997-08-21 |
| NO960309D0 (en) | 1996-01-25 |
| NO960309L (en) | 1996-01-25 |
| CN1127529A (en) | 1996-07-24 |
| FI960353A (en) | 1996-01-26 |
| NZ269663A (en) | 1997-09-22 |
| JPH08507930A (en) | 1996-08-27 |
| HUT73463A (en) | 1996-08-28 |
| KR960704041A (en) | 1996-08-31 |
| AU7399694A (en) | 1995-02-20 |
| ZA945434B (en) | 1995-01-23 |
| SG43798A1 (en) | 1997-11-14 |
| IL110413A0 (en) | 1994-10-21 |
| FI960353A0 (en) | 1996-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL312718A1 (en) | Competitors and opponents of human interleukine-10 | |
| ZA947138B (en) | Skin care method and composition | |
| IL112041A0 (en) | Methods of inhibiting atrophy of the skin and vagina | |
| CY2508B1 (en) | Benzopyrans and their use as therapeutic agents | |
| GB9413938D0 (en) | Activity toy and walker | |
| GB9412711D0 (en) | Medical use of bromelain | |
| NZ312748A (en) | Synergistic herbicidal composition and method of use thereof | |
| IL120173A0 (en) | Synergistic use of azadirachtin and pyrethrum | |
| GB9219425D0 (en) | Therapeutic agent and its use | |
| SG42309A1 (en) | Medical use of enzymes | |
| GB2294637B (en) | Therapeutic compositions and methods of use | |
| PL322002A1 (en) | Variants of human dnase i | |
| ZA947139B (en) | Skin care method and composition | |
| PL303822A1 (en) | Therapeutic compositions containing ipsapyrone and method of obtaining them | |
| EP1015559A4 (en) | Human regeneration-associated serpin-1 (rasp-1) and methods of use | |
| GB9312030D0 (en) | Preparation and use of lipo-n-acetyl-cysteine | |
| HU9400634D0 (en) | Vaccine and diagnosticum against parvovirosis of gooses and barbari duks | |
| ZA933293B (en) | Game observation and skill | |
| GB9312780D0 (en) | Therapeutic and cosmetic treatment | |
| GB9313221D0 (en) | Use of human igf-ii | |
| ZA918466B (en) | Game of skill and observation | |
| GB9326395D0 (en) | Therapeutic methods and compositions | |
| GB9525891D0 (en) | Therapeutic agents and their preparation | |
| GB9313189D0 (en) | Medical use of enzymes | |
| GB9308164D0 (en) | Medical use of enzymes |